Think buying an S&P 500 index fund means you own a piece of all 500 companies equally? Think again. The index you probably hold in your 401(k) or brokerage account has quietly become something very different from what most investors imagine, and that gap between perception and reality is widening by the year.

The S&P 500 as most people know it is cap-weighted, meaning each stock’s slice of the pie is proportional to its total market value. Apple Inc. (NASDAQ:AAPL), Microsoft Corp. (NASDAQ:MSFT), and Nvidia Corp. (NASDAQ:NVDA) are far from equal participants in that portfolio. By the end of 2025, the 10 largest companies in the index collectively accounted for nearly 41% of its total weight; more than double their share from just a decade ago, according to RBC Wealth Management. Owning a standard S&P 500 fund today is, in practical terms, placing a concentrated bet on a handful of AI-adjacent megacap tech names, whether you realize it or not.

The alternative, the S&P 500 Equal Weight Index, assigns every one of those 500 companies an identical ~0.2% allocation. Apple and a mid-sized industrial company sit on the same footing. That seemingly small structural difference can lead to dramatically different outcomes for your portfolio, depending on what the market is doing.

A 20-Year Winner Dethroned

For much of modern investing history, the equal-weight approach quietly won. From 2003 through 2022, the S&P 500 Equal Weight Index outperformed its cap-weighted counterpart by roughly 1.5% per year, largely because of size effects and periodic mean reversion among large-cap leaders, according to RBC Wealth Management data. Invesco similarly notes that the equal-weight version outperformed by an average of about 1.05% annually up until 2023.

Then the artificial intelligence wave hit, and the Magnificent Seven — Apple, Microsoft, Nvidia, Amazon, Alphabet, Meta, and Tesla — began a concentration run that has few parallels in market history. Since the start of 2023, the cap-weighted S&P 500 has outperformed the equal-weight index by roughly 32%, one of the largest three-year relative outperformances ever recorded and slightly exceeding the peak outperformance seen during the dot-com bubble in the late 1990s.

For individual investors, this stretching of the gap has a hidden personal cost: if you’ve been watching a broader equal-weight fund underperform the nightly-news benchmark for three years, the temptation is to chase the cap-weighted winner. That’s often how investors end up buying concentration risk at precisely the wrong moment.

The Math Problem Nobody Is Talking About

Here’s a framing that reshapes how you should think about future cap-weighted returns: at current valuations, the biggest companies simply face an arithmetic ceiling.

Apple is near a $4 trillion market capitalization. For that stock alone to double from here, it would need to add more in value than the combined market caps of Walmart, JPMorgan, and Pfizer. Nvidia, after its explosive AI-driven run, would need to add over $5 trillion in market cap just to double; a number no company in history has ever reached. With the cap-weighted S&P 500 now leaning on these same names for over 40% of its total weight, the index’s entire forward return trajectory is hostage to these companies’ ability to keep compounding at historic rates.

The equal-weight index faces no such structural ceiling. Because it constantly rebalances each holding back to ~0.2%, buying relative laggards and trimming relative outperformers quarterly, it naturally distributes exposure across a far wider universe of companies, including smaller names trading at mid-teen or even single-digit price-to-earnings multiples, versus the 25x to 40x multiples you’ll find at the top of the cap-weighted index.

Concentration Risk Is Real, and It’s Wider Than You Think

Valuation alone tells part of the story, but the concentration risk carries another layer that often goes unnoticed. S&P Dow Jones Indices data through March 2026 shows the equal-weight index still trailing the cap-weighted version by about 5% on a trailing twelve-month basis, with information technology underweight and smaller-cap industrials lagging as the main detractors.

What’s striking is how much of the cap-weighted index’s volatility now traces back to just a handful of highly correlated names. According to Invesco, by end of Q3 2024, the top 10 companies alone contributed to over half of the S&P 500’s total volatility, despite representing only about 35% of its weight at that time; a figure that has since risen further. Because these companies operate in closely related industries (cloud computing, semiconductors, AI infrastructure, digital advertising), their stocks tend to move together, amplifying drawdowns when sentiment in the sector shifts.

The equal-weight approach dilutes this cluster risk automatically. Every rebalance serves as a built-in discipline, pulling capital away from whatever has become dangerously large and redistributing it across the rest of the 500.

How to Play Each Side

The most straightforward way to get cap-weighted S&P 500 exposure remains the SPDR S&P 500 ETF Trust (NYSE:SPY), the iShares Core S&P 500 ETF (NYSE:IVV), or the Vanguard S&P 500 ETF (NYSE:VOO). All three carry expense ratios at or below 0.03%, which is essentially free.

For equal-weight exposure, the go-to vehicle is the Invesco S&P 500 Equal Weight ETF (NYSE:RSP), which carries a 0.20% expense ratio. That’s still extremely cost-efficient given what the structure provides: genuine exposure to all 500 names, with automatic quarterly rebalancing that enforces a buy-low, sell-high discipline across the full index universe.

The cost difference between SPY and RSP, roughly 17 basis points annually, is worth examining in context. Over a long holding period, 0.17% per year compounds, but it’s a fraction of the performance gap that can open up between the two strategies during major market rotations. When mean reversion hits the mega-caps, as it did in 2022, equal weight’s outperformance of the Magnificent Seven by 34% during that correction period far exceeded any fee drag.

The Historical Playbook on Mean Reversion

History offers a useful guide here. The cap-weighted S&P 500’s last great stretch of dominance over its equal-weight counterpart ended at the dot-com peak in early 2000, when the rolling three-year relative outperformance hit about 31%. What followed was a period in which the equal-weight index outperformed by roughly 33 percentage points cumulatively over the next few years, as the bubble deflated and capital rotated toward the broader market.

The current three-year relative outperformance of cap weight over equal weight has now surpassed that dot-com peak, according to RBC Wealth Management. That doesn’t guarantee a reversion — the Magnificent Seven are vastly more profitable than the speculative dot-com darlings were — but it does mean the structural setup for an eventual rotation is in place. Over the past 30 years, only about 3% of companies managed to sustain top-quintile sales growth for three consecutive years, per FactSet data cited by Invesco. Exceptional growth normalizes. It always has.

The Mag Seven itself offered a preview of this dynamic in 2022. After returning 51.5% in 2021 while the broader S&P 500 returned 28.7%, the group mean-reverted sharply, and the equal-weight index outperformed the Magnificent Seven by 34% during that correction.

Who Should Consider Tilting Toward Equal Weight Now

This isn’t a blanket argument to dump your S&P 500 index fund. Both strategies have a legitimate place, and the cap-weighted version remains an excellent core holding. The question is whether your current allocation reflects a conscious choice or an inadvertent concentration risk you never signed up for.

If your entire U.S. equity exposure sits in a standard cap-weighted S&P 500 fund, you are significantly overweight a cluster of AI and cloud megacap stocks, whether or not you chose them deliberately. Investors who already have meaningful direct exposure to Apple, Microsoft, Nvidia, or similar names through individual stock positions are doubling down on that concentration unknowingly.

A practical approach many portfolio managers are exploring is a blend: keeping a core position in a low-cost cap-weighted fund for liquidity and benchmark tracking, while adding a sleeve of RSP or similar equal-weight exposure to dilute concentration risk and provide a potential catch-up trade if market breadth expands. CME Group’s data shows that utilization of equal-weight futures products jumped 34% year-over-year in 2025, signaling that institutional investors are already moving in this direction.

The underlying question every investor should be asking is straightforward: Do you want your portfolio’s future returns to depend primarily on whether Apple, Microsoft, and Nvidia can keep growing into increasingly improbable valuations? Or do you want exposure to the other 490-plus companies in the index that are, by most fundamental measures, far cheaper, and have historically done well when the market’s leadership eventually broadens?

The S&P 500 was never designed to be a concentrated megacap tech fund. Right now, for better or worse, that’s largely what it is.

image credit: Author

Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga’s reporting and has not been edited for content or accuracy.